| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |